153 related articles for article (PubMed ID: 34232789)
1. Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Polish Perspective.
Derwich K; Brzezinski A; Karpenko C; Morar V; Atukoralalage U
J Adolesc Young Adult Oncol; 2022 Feb; 11(1):1-5. PubMed ID: 34232789
[TBL] [Abstract][Full Text] [Related]
2. Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
Siegel SE; Stock W; Johnson RH; Advani A; Muffly L; Douer D; Reed D; Lewis M; Freyer DR; Shah B; Luger S; Hayes-Lattin B; Jaboin JJ; Coccia PF; DeAngelo DJ; Seibel N; Bleyer A
JAMA Oncol; 2018 May; 4(5):725-734. PubMed ID: 29450465
[TBL] [Abstract][Full Text] [Related]
3. Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase.
Boissel N; Sender LS
J Adolesc Young Adult Oncol; 2015 Sep; 4(3):118-28. PubMed ID: 26421220
[TBL] [Abstract][Full Text] [Related]
4. Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Matsushima S; Kobayashi R; Sano H; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
Pediatr Blood Cancer; 2021 Feb; 68(2):e28763. PubMed ID: 33047887
[TBL] [Abstract][Full Text] [Related]
5. Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).
Rytting ME; Thomas DA; O'Brien SM; Ravandi-Kashani F; Jabbour EJ; Franklin AR; Kadia TM; Pemmaraju N; Daver NG; Ferrajoli A; Garcia-Manero G; Konopleva MY; Cortes JE; Borthakur G; Garris R; Cardenas-Turanzas M; Schroeder K; Jorgensen JL; Kornblau SM; Kantarjian HM
Cancer; 2014 Dec; 120(23):3660-8. PubMed ID: 25042398
[TBL] [Abstract][Full Text] [Related]
6. Detection of anti-asparaginase antibodies during therapy with E.coli asparaginase in children with newly diagnosed acute lymphoblastic leukemia and lymphoma.
Ebeid EN; Kamel MM; Ali BA
J Egypt Natl Canc Inst; 2008 Jun; 20(2):127-33. PubMed ID: 20029468
[TBL] [Abstract][Full Text] [Related]
7. Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols.
Valtis YK; Flamand Y; Shimony S; Place AE; Silverman LB; Vrooman LM; Brunner AM; Sallan SE; Wadleigh M; Stone RM; DeAngelo DJ; Luskin MR
Leukemia; 2024 Mar; 38(3):482-490. PubMed ID: 38177437
[TBL] [Abstract][Full Text] [Related]
8. Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment.
Janardan SK; Miller TP
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):581-586. PubMed ID: 38066874
[TBL] [Abstract][Full Text] [Related]
9. Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Muffly L; Lichtensztajn D; Shiraz P; Abrahão R; McNeer J; Stock W; Keegan T; Gomez SL
Cancer; 2017 Jan; 123(1):122-130. PubMed ID: 27622953
[TBL] [Abstract][Full Text] [Related]
10. Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
Rytting ME; Jabbour EJ; Jorgensen JL; Ravandi F; Franklin AR; Kadia TM; Pemmaraju N; Daver NG; Ferrajoli A; Garcia-Manero G; Konopleva MY; Borthakur G; Garris R; Wang S; Pierce S; Schroeder K; Kornblau SM; Thomas DA; Cortes JE; O'Brien SM; Kantarjian HM
Am J Hematol; 2016 Aug; 91(8):819-23. PubMed ID: 27178680
[TBL] [Abstract][Full Text] [Related]
11. Remission Rate of Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA).
Vallacha A; Haider G; Raja W; Kumar D
J Coll Physicians Surg Pak; 2018 Feb; 28(2):118-121. PubMed ID: 29394970
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia in young adults: which treatment?
McNeer JL; Raetz EA
Curr Opin Oncol; 2012 Sep; 24(5):487-94. PubMed ID: 22691923
[TBL] [Abstract][Full Text] [Related]
13. Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.
McNeer JL; Bleyer A
Pediatr Blood Cancer; 2018 Jun; 65(6):e26989. PubMed ID: 29418064
[TBL] [Abstract][Full Text] [Related]
14. Trends in survival of leukemia among children, adolescents, and young adults: A population-based study in Osaka, Japan.
Nakata K; Okawa S; Fuji S; Sato A; Morishima T; Tada Y; Inoue M; Hara J; Kawa K; Miyashiro I;
Cancer Sci; 2021 Mar; 112(3):1150-1160. PubMed ID: 33428808
[TBL] [Abstract][Full Text] [Related]
15. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Stock W; La M; Sanford B; Bloomfield CD; Vardiman JW; Gaynon P; Larson RA; Nachman J; ;
Blood; 2008 Sep; 112(5):1646-54. PubMed ID: 18502832
[TBL] [Abstract][Full Text] [Related]
16. Asparaginase in acute lymphoblastic leukemia.
Kawedia JD; Rytting ME
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S14-7. PubMed ID: 25486949
[TBL] [Abstract][Full Text] [Related]
17. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R
Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991
[TBL] [Abstract][Full Text] [Related]
18. Acute lymphoblastic leukemia in adolescents and young adults.
Burke PW; Douer D
Acta Haematol; 2014; 132(3-4):264-73. PubMed ID: 25228551
[TBL] [Abstract][Full Text] [Related]
19. Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study.
Muffly L; Alvarez E; Lichtensztajn D; Abrahão R; Gomez SL; Keegan T
Blood Adv; 2018 Apr; 2(8):895-903. PubMed ID: 29669756
[TBL] [Abstract][Full Text] [Related]
20. Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Vignon M; Andreoli A; Dhédin N; Lengliné E; Masson E; Robin M; Granier C; Larghero J; Schlageter MH; de Latour RP; Socié G; Boissel N
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):299-306. PubMed ID: 27983886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]